1. Home
  2. CBT vs HLN Comparison

CBT vs HLN Comparison

Compare CBT & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBT
  • HLN
  • Stock Information
  • Founded
  • CBT 2019
  • HLN 2022
  • Country
  • CBT United States
  • HLN United Kingdom
  • Employees
  • CBT N/A
  • HLN N/A
  • Industry
  • CBT Major Chemicals
  • HLN Package Goods/Cosmetics
  • Sector
  • CBT Industrials
  • HLN Consumer Discretionary
  • Exchange
  • CBT Nasdaq
  • HLN Nasdaq
  • Market Cap
  • CBT 4.0B
  • HLN 48.2B
  • IPO Year
  • CBT N/A
  • HLN N/A
  • Fundamental
  • Price
  • CBT $78.64
  • HLN $9.96
  • Analyst Decision
  • CBT Hold
  • HLN Buy
  • Analyst Count
  • CBT 3
  • HLN 1
  • Target Price
  • CBT $92.67
  • HLN $10.95
  • AVG Volume (30 Days)
  • CBT 380.5K
  • HLN 13.5M
  • Earning Date
  • CBT 08-04-2025
  • HLN 07-31-2025
  • Dividend Yield
  • CBT 2.29%
  • HLN 1.78%
  • EPS Growth
  • CBT N/A
  • HLN 38.94
  • EPS
  • CBT 7.72
  • HLN 0.20
  • Revenue
  • CBT $3,908,000,000.00
  • HLN $14,062,871,660.00
  • Revenue This Year
  • CBT N/A
  • HLN $3.63
  • Revenue Next Year
  • CBT $3.55
  • HLN $4.37
  • P/E Ratio
  • CBT $10.16
  • HLN $25.12
  • Revenue Growth
  • CBT N/A
  • HLN N/A
  • 52 Week Low
  • CBT $71.64
  • HLN $8.68
  • 52 Week High
  • CBT $117.46
  • HLN $11.42
  • Technical
  • Relative Strength Index (RSI)
  • CBT 56.99
  • HLN 26.82
  • Support Level
  • CBT $76.17
  • HLN $10.01
  • Resistance Level
  • CBT $79.61
  • HLN $10.15
  • Average True Range (ATR)
  • CBT 1.75
  • HLN 0.11
  • MACD
  • CBT 0.35
  • HLN -0.04
  • Stochastic Oscillator
  • CBT 81.81
  • HLN 3.68

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: